Home
About
Pricing
Log In

What are you looking for?

Home
Pricing
Back
Compare AU

Compare BGBL vs. CURE

Compare shares and ETFs on the ASX that you can trade on Pearler.

Betashares Global Shares ETF

ASX

Buy

Buy

Global X S&P Biotech ETF

ASX

Overview
Industry & Region

Industry & Region

Country Exposure

BGBL

CURE

United States

72.14 %

96.62 %

Japan

6.29 %

United Kingdom of Great Britain and Northern Ireland

3.69 %

1.35 %

Canada

3.58 %

Switzerland

2.43 %

1.13 %

Germany

2.32 %

France

2.26 %

Netherlands

1.40 %

0.73 %

Sweden

0.98 %

Spain

0.88 %

Italy

0.74 %

Singapore

0.54 %

Hong Kong

0.51 %

Denmark

0.47 %

Israel

0.33 %

Belgium

0.24 %

Finland

0.22 %

Norway

0.19 %

China

0.14 %

Poland

0.14 %

Ireland

0.13 %

0.16 %

Brazil

0.12 %

Austria

0.11 %

New Zealand

0.06 %

Portugal

0.05 %

Malaysia

0.02 %

Mexico

0.01 %

Australia

0.01 %

Industry Exposure

icon for key differences panel

Key differences

  • β€’

    BGBL has a higher allocation (29.74 %) in the Other sector than CURE (10.24 %).

  • β€’

    The most popular industries that BGBL is exposed to are Other (29.74 %), Information Technology (25.04 %), and Financials (8.88 %). Comparatively, CURE is most exposed to Health Care (100.00 %), and Other (10.24 %).

BGBL

CURE

Other

29.74 %

10.24 %

Information Technology

25.04 %

Financials

8.88 %

Consumer Discretionary

7.78 %

Health Care

6.43 %

100.00 %

Communication Services

6.18 %

Industrials

5.97 %

Consumer Staples

3.75 %

Energy

2.04 %

Utilities

1.62 %

Real Estate

1.29 %

Materials

1.28 %